BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,280.00
0.00 (0.00%)
Last updated: Sep 19, 2025, 11:15 AM KST
Market Cap25.20B
Revenue (ttm)24.47B
Net Income (ttm)-4.60B
Shares Out4.86M
EPS (ttm)-946.41
PE Ration/a
Forward PEn/a
Dividend400.00 (7.58%)
Ex-Dividend DateDec 27, 2024
Volume3,110
Average Volume4,400
Open5,230.00
Previous Close5,280.00
Day's Range5,210.00 - 5,280.00
52-Week Range4,965.00 - 11,580.00
Beta0.84
RSI39.29
Earnings Daten/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.